HyperLink
Field Detail
Theme Health
Code PH-SXH-1.6
MDG code MDG-6.5
Sub-theme Sexual Health (HIV/AIDS & STI)
Name Proportion of population with HIV infection with access to ARV drugs (MDG 6.5)
Definition Proportion of individuals living with HIV infection who are currently receiving ARV as a percentage of all individuals living with HIV infection who are eligible to receive ARV under current treatment protocols. [UN definition = The percentage of adults and children with advanced HIV infection currently receiving antiretroviral therapy according to nationally approved treatment protocols (or WHO/Joint UN Programme on HIV and AIDS standards) among the estimated number of people with advanced HIV infection. The numerator (the number of people receiving antiretroviral therapy) is derived from national programme reporting systems, aggregated from health facilities or other service delivery sites. The denominator (the total number of people who need antiretroviral therapy) is generated using a standardized statistical modelling approach. The number of adults with advanced HIV infection who should start treatment is estimated based on the assumption that the average time from HIV seroconversion to eligibility for antiretroviral therapy is eight years and, without antiretroviral therapy, the average time from eligibility to death is about three years. These parameters were revised in 2007: the previous estimates were based on the assumption of seven years from seroconversion to eligibility and two years from eligibility to death in the absence of treatment].
Calculation/Formula Number of people receiving antiretroviral therapy / Total number of people who need antiretroviral therapy x 100
Unit of Measure %
Limitations Although this indicator allows trends to be monitored over time, it does not attempt to distinguish between the different types of treatment regimens available nor does it measure the cost, quality or effectiveness of treatment, or adherence to treatment regimes
Purpose/Rationale Provision of antiretroviral therapy to all eligible individuals is an indicator of progress toward reducing death and disability from HIV infection
Policy Linkages Pacific Regional Strategy on HIV and other STIs and Implementation Plan 2009-2016
Preferred Data Sources National Health Information System (Administrative Data): Facility based client registers or drug supply management systems
Primary Data Collection System National Administrative Database - Health Information Management Systems (HIS)
Frequency of Data Collection Annual
Other agencies countries_ must report to: CHIPS, IATT, UNICEF, UNAIDS/UNGASS, Global Fund
SPC Responsibility - Data Management PHD
Baseline Year 2008
Baseline value 2008: available for 5 PICTs: FSM, Kiribati, Samoa, Palau, Vanuatu- all 100%
Target value 100% each year in 9 PICTs. (3 PICTs do not have PLWH on ART)
Data validation / quality The number of new ART cases is very low in the whole region and does not involve all the 9 PICTs - at a given point.
SPC Programme PHD
Numerator Number of people receiving antiretroviral therapy
Denominator Total number of people who need antiretroviral therapy
Factor x 100
Unit %
Other Metadata Link http://mdgs.un.org/unsd/mdg/Metadata.aspx